网站大量收购独家精品文档,联系QQ:2885784924

CT导向下125I粒子植入术联合化疗治疗结直肠癌肝转移的疗效观察.DOC

CT导向下125I粒子植入术联合化疗治疗结直肠癌肝转移的疗效观察.DOC

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
CT导向下125I粒子植入术联合化疗治疗结直肠癌肝转移的疗效观察

注意上标125I CT引导下植入125I放射性粒子联合化疗治疗结直肠癌肝转移的疗效分析 张念华 陈高峰 李寿杰 高海利 武如通 (广东省第二中医院肿瘤科 广州510095) 摘要:目的:评价CT引导下植入125I放射性粒子联合化疗治疗结直肠癌肝转移的临床价值。方法:选取42例在我科接受化疗的结直肠癌肝转移患者,随机分为两组,其中研究组21例,在化疗的同时并植入125I放射性粒子治疗,对照组21例,仅接受化疗。对所有患者按实体瘤疗效评价标准进行评价。结果:研究组完全缓解2例、部分缓解16例、稳定3例、进展0例,对照组完全缓解0例、部分缓解11例、稳定8例、进展2例。研究组客观反应率为85.7%(18/21),对照组客观反应率为52.4%(11/21),研究组的客观反应率较对照组明显升高(P=0.022)。治疗过程中两组均未发现严重不良事件,大多不良反应都是轻微、一过性的。两组在Ⅲ~Ⅳ度毒性反应方面并无明显差异。结论:CT引导下植入125I放射性粒子联合化疗治疗结直肠癌肝转移在提高临床疗效的同时,不良反应并未增加。 关键词:结直肠癌肝转移;化疗;125I放射性粒子;近距离放射疗法 Clinical Observation of CT Guided 125I Implantation Combined with Chemotherapy in Treating Liver Metastasis of Colorectal Cancer ZHANG Nian-hua, CHEN Gao-feng, SHI Qing-hua, LI Shou-jie, GAO Hai-li, WU Ru-tong (The Department of Oncology, Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou510095) Abstract: Objective: To evaluate the clinical value of CT guided 125I implantation combined with chemotherapy in treating liver metastasis of colorectal cancer. Methods: 42 Colorectal cancer patients with liver metastasis were received chemotherapy in our department, 21 patients were assigned to receive chemotherapy combined with CT guided radioactive 125I implantation (experimental group), while another 21 patients received chemotherapy alone (control group). The effects were evaluated according to response evaluation criteria in solid tumors. Results: In the experimental group, complete response (CR) was 2, 16 had partial response (PR), 3 had stable disease (SD), and 0 had progressive disease (PD). While in the control group, CR was 0, 11 had PR, 8 had SD, and 2 had PD. The objective reaction rate in the experimental group was 85.7% (18/21), which was 52.4% (11/21) in the control group, the experimental group was higher than that in the control group (P=0.022). During the follow-up periods, most toxicity were low-grade and transient, and clinically significant adverse event was not observed. The Ⅲ~Ⅳ toxicities during treatments in the experimental group an

文档评论(0)

zhaoxiaoj + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档